- Home
- |
- About
- |
- MC-1 for PNPO Deficiency
- |
- Products
- |
- Newsroom
- |
- Investors
- |
- Contact Us
Medicure Inc.'s recent acquisition of Marley Drug demonstrates its commitment to addressing the rising cost of prescription medications in the United States.
This acquisition helps Medicure to expand its presence in the U.S. market. Marley Drug is known for its low prices and personalized service and has a long history of serving patients who may not have insurance coverage or who may have limited financial resources. Patients can expect to see even greater access to affordable medications and personalized service in the years to come.
No PBM (Pharmacy Benefit Manager) fees
Copyright © 2026 Medicure Inc. All Rights Reserved. | Privacy Policy | Your Privacy Choices | Cookie Preferences